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Protein 3-nitrotyrosine is a post-translational modification that commonly arises
from the nitration of tyrosine residues. This modification has been detected
under a wide range of pathological conditions and has been shown to alter
protein function. Whether 3-nitrotyrosine is important in normal cellular pro-
cesses or is likely to affect specific biological pathways remains unclear.
Using GPS-YNO2, a recently described 3-nitrotyrosine prediction algorithm, a
set of predictions for nitrated residues in the human proteome was generated.
In total, 9.27 per cent of the proteome was predicted to be nitratable (27 922/
301 091). By matching the predictions against a set of curated and experi-
mentally validated 3-nitrotyrosine sites in human proteins, it was found that
GPS-YNO2 is able to predict 73.1 per cent (404/553) of these sites. Furthermore,
of these sites, 42 have been shown to be nitrated endogenously, with 85.7 per
cent (36/42) of these predicted to be nitrated. This demonstrates the feasibility
of using the predicted dataset for a whole proteome analysis. A comprehensive
bioinformatics analysis was subsequently performed on predicted and all
experimentally validated nitrated tyrosine. This found mild but specific bio-
physical constraints that affect the susceptibility of tyrosine to nitration, and
these may play a role in increasing the likelihood of 3-nitrotyrosine to affect pro-
cesses, including phosphorylation and DNA binding. Furthermore, examining
the evolutionary conservation of predicted 3-nitrotyrosine showed that, relative
to non-nitrated tyrosine residues, 3-nitrotyrosine residues are generally less con-
served. This suggests that, at least in the majority of cases, 3-nitrotyrosine is
likely to have a deleterious effect on protein function and less likely to be
important in normal cellular function.2. Introduction
Protein 3-nitrotyrosine is a post-translational modification (PTM) of the amino
acid tyrosine, with the covalent substitution of a nitrite group positioned in the
3-position in the aromatic phenol of tyrosine [1]. The modification is mediated
by reactive nitrogen species and can be formed under a number of physiological
conditions [2–4]. One of the most well-known pathways through which tyro-
sine is nitrated is from the reactive nitrating intermediate peroxynitrite
(ONOO2). Peroxynitrite is formed in vivo via the fast reaction between super-
oxide (O2




2enzyme nitric oxide synthase, respectively [5,6]. As such, the
3-nitrotyrosine has been found to be elevated during inflam-
matory processes where immuno-inflammatory cells and
nitric oxide levels are elevated [7,8]. As inflammation has
been linked to a wide range of human pathological conditions,
3-nitrotyrosine has now also been observed in a large number
of diseases, including lung cancer, cardiovascular disease,
asthma and Alzheimer’s disease [9–14].
Although many studies have identified the presence
of 3-nitrotyrosine, knowledge of how this PTM generally
affects protein function remains limited [15–17]. The nitro
functional group represents a bulky neutral moiety that is
likely to have an influence in the normal biology of tyrosine.
Indeed, crystal structure analyses of manganese superoxide
dismutase show that the inhibition of catalytic activity is
due to the steric effect of 3-nitrotyrosine in impeding sub-
strate access and binding. Furthermore, the close proximity
of 3-nitrotyrosine to a glutamine in the active site alters the
hydrogen bond network that supports proton transfer in
catalysis [18]. In a separate study, the protein thioredoxin-1 dis-
played inactivation by 3-nitrotyrosine, blocking the protein’s
natural anti-apoptotic and cardio-protective effects [19,20].
Furthermore, it has been proposed that the nitration of tyrosine
may directly prevent phosphorylation of the same residue,
thereby preventing important phosphotyrosine-mediated
signalling cascades [21–24]. Conversely, at the cellular level,
tyrosine nitration has been shown to increase the overall level
of phosphotyrosine in the proteome [23,25–28]. Collectively,
current evidence suggests that there is potential biological
significance of the formation of 3-nitrotyrosine in causing
abnormal cellular function.
The analysis of 3-nitrotyrosine in biological samples
has presented challenges [29]. In part, this is probably
owing to the low abundance of the PTM, limiting the ability
to pinpoint the specific sites of tyrosine nitration. To date,
the majority of studies have been performed using immuno-
affinity-based techniques to identify proteins that are
tyrosine-nitrated [30,31]. A limitation of these studies is that
they are generally unable to pinpoint the specific tyrosine
residues that are affected. Furthermore, the possibility of
the antibody binding to non-specific epitopes is difficult to
exclude in experiments, thus this may result in false positive
detection. In recent years, development of derivatization
strategies coupled with modern mass spectrometry analysis
has allowed substantial progress to be made in terms of the
identification of specific proteins and sites of tyrosine
nitration under both in vitro and in vivo conditions [32–34].
By reducing and therefore functionalizing the 3-nitrotyrosine
into a 3-aminotyrosine and pre-blocking other primary
amines, Zhang et al. [35] were able to specifically biotinylate,
enrich and identify 150 unique 3-nitrotyrosine-containing
peptides corresponding to 102 proteins from an in vitro
nitrated rat brain extract. More recently, Ghesquiere et al.
[36] applied diagonal chromatography by taking advantage
of a hydrophilic shift upon the reduction of 3-nitrotyrosine
into 3-aminotyrosine to identity 3-nitrotyrosines. In that
study, 335 3-nitrotyrosine-containing peptides corresponding
to 267 proteins in an in vitro nitrated Jurkat cell extract and six
3-nitrotyrosine-containing peptides from four mouse proteins
extracted from mouse serum were successfully identified and
enriched [36].
Early studies suggested that there is either no consensus
motif around nitrated tyrosine residues [37,38] or, even ifthere is, it is probably loosely defined [39]. Nevertheless,
with a growing body of experimentally verified nitration
sites, a computational model (GPS-YNO2) was developed
for predicting tyrosine residues that are susceptible to
nitration based on the biochemical properties of amino
acids adjacent to tyrosine [40]. Using cross-validation, the
model was shown to predict 3-nitrotyrosine with an accuracy
of over 76 per cent and a specificity of 80.18 per cent.
The lack of experimentally verified susceptible sites
has made it difficult to examine global biophysical and
evolutionary trends of 3-nitrotyrosine. The ability to predict 3-
nitrotyrosine provides an opportunity to examine the impact
of this PTM at the proteome level. Using the reference human
proteome, a comprehensive computational analysis of tyrosine
residues predicted to be susceptible to nitration was performed.
The prediction of 3-nitrotyrosine residues was first validated
against sites that have been previously experimentally ident-
ified in human proteins. Subsequently, some biophysical
and biochemical properties of predicted and experimentally
validated 3-nitrotyrosine residues were examined. Further-
more, the overlap of tyrosine residues that are susceptible to
both phosphorylation and nitration was analysed. Finally, by
tracking the conservation of tyrosine across mammalian ortho-
logous proteins, whether nitrated tyrosine residues are under
selective pressure in natural protein evolution was examined.3. Material and methods
3.1. Prediction of 3-nitrotyrosine in the human
proteome
Canonical protein sequences from all curated human proteins
were obtained in FASTA format from the UniProt/Swiss-Prot
database (release 2012_04). To predict 3-nitrotyrosine in all
human proteins, the local version of GPS-YNO2 (v. 1.0)
was used. The batch predictor tool was used to import and
analyse all human proteins. All threshold levels (high,
medium and low) were used initially to generate a complete
list of predicted 3-nitrotyrosine sites (see electronic sup-
plementary material, table S1 for list of counts). Since the
high threshold still resulted in a relatively large number of
3-nitrotyrosine sites, for all ensuing analysis, only these
sites were used (27 922 tyrosine residues). The list of pre-
dicted sites was merged with UniProt sequence annotations
and exported for further analysis. A full table summarizing
the annotations of all tyrosine residues in human UniProt
proteins can be found in the electronic supplementary
material, table S2.
3.2. Curation of experimentally identified
3-nitrotyrosine residues in human proteins
Human protein nitration sites retrieved from supplementary
table S1 of Liu et al. [40] and from literature published since
2011 retrieved from PubMed using the search term ‘tyrosine
nitration’ were reviewed manually. In total, 553 tyrosine sites
have experimental evidence for nitration. The proteins and
sites were determined to be endogenously nitrated in vivo
only if they had been identified from untreated human
samples using mass spectrometry. The in vivo sites were




3proteome dataset using the UniProt/Swiss-Prot accession
and labelled accordingly in electronic supplementary
material, table S2. This resulted in a final set of 42 in vivo vali-
dated 3-nitrotyrosine sites in the human proteome.
3.3. Gene-annotation enrichment analysis of tyrosine-
nitrated proteins
All human proteins that had one or more predicted nitrated
sites were considered to be nitrated (12 338), while those
without any predicted nitration sites were considered not to
be nitrated (7407). Gene annotation enrichment analysis
was performed using DAVID [41], with nitrated proteins as
the gene set and the non-nitrated proteins as background.
Enriched biological themes were determined using the
UniProt keyword annotations. As a further control for enrich-
ment, random lists of 12 338 proteins were generated to
validate that features reported to be enriched in nitrated
proteins are indeed true positives.
3.4. Structural analysis of tyrosine susceptible
to nitration
As of April 2012, there were 15 466 X-ray crystal structures
of human proteins in the Protein Data Bank (PDB) which
map to 3500 proteins from UniProt/Swiss-Prot database.
Of these, 2399 nitrated proteins contain 5815 predicted
3-nitrotyrosine sites, while 35 nitrated proteins contain 81
experimentally validated 3-nitrotyrosine sites. To determine
the solvent accessibility and the secondary structure of tyrosine
residues, all X-ray structures were downloaded in PDB format
and analysed using DSSP [42]. The solvent accessibility values
were used as generated by DSSP. The secondary structural
information was further grouped into helix (H, G, I), strand
(B, E), turn (T, S) and loop/random (blank), where the
corresponding DSSP output code is listed in the brackets.
3.5. Two Sample Logo analysis
To examine the amino acid composition adjacent to tyro-
sine residues, Two Sample Logo [43] was used. The Two
Sample Logo tool generates a sequence logo that shows amino
acids that are statistically significantly enriched or depleted
across sequences generated under two conditions. Sequences
+10 residues of all tyrosine residues were aligned based on the
tyrosine residue of interest. Where an N- or C-terminus falls
within the +10 residues, the remaining residues were padded
with gaps. To generate the Two Sample Logos, the sequences
centred around potentially nitrated tyrosine were compared
with sequences centred around non-nitratable tyrosine residues.
The t-test was selected to evaluate statistical significance and col-
ouring of residues was based on a-helix propensity as described
by Pace & Scholtz [44] or based on charge.
3.6. Overlap with phosphotyrosine residues
Phosphotyrosine annotations were obtained from Phospho-
SitePlus [45] (12 268). To determine whether predicted and
experimentally validated 3-nitrotyrosine are more likely to
overlap with phosphorylated tyrosine residues than by
chance, an equal number of all tyrosine residues were
randomly selected and counted for overlap withphosphotyrosine residues. The bootstrapping process was
repeated 500 times to assess statistical significance.
3.7. Conservation of nitrated tyrosine residues
To determine the conservation of tyrosine through protein
evolution, orthologous proteins from 10 mammalian species
(Homo sapiens, Pan troglodytes, Mus musculus, Rattus norvegi-
cus, Bos taurus, Sus scrofa, Equus caballus, Canis familiaris,
Monodelphis domestica and Ornithorhynchus anatinus) were
compared. Orthologous protein clusters and sequences
were obtained from ORTHODB (v. 5) [46]. Only orthologous
clusters where the human protein can be mapped to a Uni-
Prot accession and where all 10 species are present were
used for analysis of conservation (6394). The protein
sequences for each species from each cluster were then
retrieved and aligned with CLUSTALW2 [47] using default par-
ameters. To determine the conservation, a tyrosine is
considered non-conserved if it was substituted by another
amino acid or by a gap of fewer than five residues in
length. The choice of gap size is based on the observation
that gaps of moderate size are often the result of a missing
protein domain or the truncation of a protein and are likely
to have arisen from a more significant change in protein func-
tion than can be attributed to the loss or gain of a tyrosine
residue. To quantify the conservation of each tyrosine,






where N is the number of types of residues found and ia is the
number of residues of type a. A higher value (upper limit
of 1) represents a site with a high number of substitutions,
while a fully conserved site will have a value of zero. A tyro-
sine was considered to be conserved if C was zero and not
conserved if C was greater than zero. The conservation
status of all tyrosine residues with orthologous proteins
across the 10 mammalian species is summarized in electronic
supplementary material, table S3.4. Results
4.1. GPS-YNO2 predicts in vivo 3-nitrotyrosine residues
with good accuracy
To ensure that the 3-nitrotyrosine predictions by GPS-YNO2
are representative of the true state of tyrosine nitration
in vivo, experimentally identified in vivo nitrated residues
from the literature were manually curated. This resulted in
the identification of 42 sites, of which 36 (85.7%) were also
predicted to be nitrated by GPS-YNO2 (see electronic
supplementary material, table S2 for a list of these sites).
4.2. Frequency of 3-nitrotyrosine correlates with total
tyrosine residues in proteins
While the formation of many PTMs is catalysed by specific
enzymes, and in particular both the formation and reversal
of almost all regulatory modifications are catalysed by
specific enzymes, to date, none has been identified for
tyrosine nitration. To investigate the biophysical and
50
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Figure 1. Distribution of (a) nitrated, (b) random (representative from 10 trials) and (c) phosphorylated tyrosine residues versus total tyrosine residues in UniProt/
Swiss-Prot proteins. The distribution of the fraction of tyrosine residues that are nitrated is also shown as a histogram (d ) where, for this study, any protein with no





evolutionary trends of tyrosine nitration on the human
proteome, tyrosine residues were annotated as nitrated or
non-nitrated based on the prediction of GPS-YNO2 [40].
To determine whether the occurrence of 3-nitrotyrosine
correlates with the frequency of occurrence of tyrosine
in proteins, the number of 3-nitrotyrosine was correlated
with the total number of tyrosine residues in each protein
(figure 1a). As control, an equal number of tyrosine residues
were randomly selected across the proteome and these random
tyrosine residues were also correlated with total tyrosine in
their respective protein (figure 1b). 3-nitrotyrosine residues
show moderate correlation with total tyrosine (R2 ¼ 0.334)
when compared with the correlation between randomly
distributed tyrosine and total tyrosine (R2 ¼ 0.576). The differ-
ence between the distribution of 3-nitrotyrosine was further
compared with randomly selected tyrosine residues and was
found to be significantly different ( p , 0.0001, paired two-
tailed t-test). In contrast, the distribution of different sets of ran-
domly generated tyrosine residues was never significant over
10 trials ( p . 0.2, paired two-tailed t-test). This indicates that
while the numbers of predicted 3-nitrotyrosine residues gener-
ally increase with numbers of tyrosine residues in a protein, it is
nevertheless not completely random.
To determine how the distribution of 3-nitrotyrosine com-
pare with those of PTMs with known enzymatic regulation,
the correlation of phosphotyrosine and total tyrosine residues
was also determined (figure 1c). This correlation is signifi-
cantly lower compared with 3-nitrotyrosines (R2 ¼ 0.076;
p , 0.0001, paired two-tailed t-test).4.3. Proteins susceptible to tyrosine nitration are
enriched for specific biological features
All proteins were then separated into two categories (nitrated
or non-nitrated) based on whether there is any nitrated tyrosine
at all in a particular protein (figure 1d). The nitrated proteinswere evaluated for the enrichment of biological features
using DAVID (table 1). The most significantly enriched terms
are ‘phosphoprotein’ and ‘coiled coil’.
To rule out any bias in gene functional enrichment, an
equal number of genes were randomly selected for analysis
in DAVID. As expected, no features were significantly
enriched in these sets beyond p . 0.1 (data not shown), indi-
cating that nitrated proteins are indeed enriched for specific
functional classes.4.4. Nitrated tyrosine residues are generally more
solvent-accessible and more likely to occur in
a-helices compared with non-nitratable
tyrosine residues
To determine the relationship between nitrated tyrosine the
tertiary structure of proteins, all tyrosine residues were
mapped to the PDB, where an X-ray crystal structure is avail-
able. Using DSSP, the solvent accessibility and secondary
structure of each tyrosine was determined. For the analysis,
tyrosine residues were separated into nitrated and non-
nitrated. Comparing the distribution of solvent accessibility,
predicted nitrated tyrosines are found to be significantly
more solvent-accessible compared with non-nitrated tyrosine
residues (figure 2a; p ¼ 0.0011, Mann–Whitney U-test).
Experiment validated nitrotyrosines showed a similar trend
of higher solvent accessibility compared with non-nitrated
tyrosine. However, the difference was not strongly significant
( p ¼ 0.0513, Mann–Whitney U-test). In terms of protein sec-
ondary structure, predicted nitrated tyrosine residues are
distributed significantly differently to non-nitrated tyrosine
residues (figure 2b; p , 0.0001, x2-test). While experimentally
validated nitrated tyrosines show a very similar trend, again
the difference is not statistically significant ( p ¼ 0.1979,



























































Figure 2. Structural analysis of nitrated tyrosine residues based on PDB X-ray crystal structures. (a) The solvent accessibility of predicted nitrated tyrosine residues
(nitro) is significantly higher than all other tyrosine residues (other; **p ¼ 0.0011, Mann – Whitney U-test). Experimentally validated nitrated tyrosine residues
(expt. valid. nitro) similarly show an increase in solvent accessibility compared with other tyrosine residues, but the difference is not statistically significant
( p ¼ 0.0521, Mann – Whitney U-test). (b) Distribution of nitrated tyrosine and other tyrosine residues across the different protein secondary structure classes.
The distribution of secondary structure between predicted nitrated tyrosine and other tyrosine is significantly different ( figure 2b; p , 0.0001, x2-test), with helices
more enriched in nitrated tyrosine residues. Experimentally validated nitrated tyrosines again show a similar trend to the predicted tyrosine residues, but the
difference is not significant compared with other tyrosine residues ( p ¼ 0.1979, x2-test).
Table 1. Top 10 enriched UniProt features in nitrated proteins versus a
non-nitrated protein background as determined using DAVID [41].
term gene count adjusted p-value
phosphoprotein 5325 1.9  10 – 154
coiled coil 1654 6.3  10 – 95
alternative splicing 5118 1.9  10 – 54
cytoplasm 2413 3.4  10 – 46
nucelotide binding 1299 6.9  10 – 44
ATP binding 1048 1.5  10 – 43
acetylation 1916 3.4  10 – 37
polymorphism 7508 2.8  10 – 34
nucleus 2955 6.7  10 – 30





enriched in a-helices compared with b-strand secondary
structures ( p , 0.0001, x2-test).
4.5. Helix propensity and charged amino acids are
enriched adjacent to 3-nitrotyrosine residues
To determine whether there is indeed an enrichment of
amino acids with propensity for a-helix formation adjacent
to 3-nitrotyrosine residues, Two Sample Logos were created
for +10 residues adjacent to the tyrosine residues. Predicted
or experimentally validated nitrated tyrosine residues were
selected as the ‘positive sample’ and non-nitrated tyrosine
as ‘negative sample’. The amino acids that have high pro-
pensity to be found in a-helices are shown in red in the
logo. It is evident that high-helix-propensity amino acids
are enriched surrounding both predicted and experimentally
validated 3-nitrotyrosine compared with unmodified tyrosine
residues (figure 3a,b). On the other hand, amino acids that
have very low a-helix propensities, such as proline andglycine, are particularly depleted around predicted nitrated
tyrosine residues (figure 3a). To investigate whether there
are specific sequence features beyond the enrichment of
high-helix-propensity amino acids around nitrated tyrosine
residues, the sequence adjacent to the subset of nitrated and
non-nitrated tyrosine residues that are present in helices
were compared (figure 3a). Charged amino acids lysine and
glutamic acid were most significantly enriched in the nitrated
tyrosines located in helices.4.6. Phosphotyrosine residues are more likely to be
nitratable than by chance
The phosphorylation of tyrosine in proteins is one of the most
important regulatory mechanisms in cell signalling. Many
diseases (including cancer) arise through dysregulation of
tyrosine kinases [49,50]. Nitration of tyrosine has been
shown to abolish [22] or at least interfere with [21] the ability
of tyrosine residues to be phosphorylated. It is therefore
important to establish the susceptibility of phosphotyrosine
residues to be nitrated in the human proteome.
A total of 12 268 tyrosine residues from 5325 proteins
were found to be annotated as phosphorylated in Phospho-
SitePlus. Of these tyrosine residues, a total of 1987 (16.2%)
were found to be predicted to be nitratable (figure 4a),
while 155 (1.3%) have been shown to be nitrated experi-
mentally (figure 4b). To determine whether this overlap
is more statistically significant than can be expected by
chance alone, 12 268 tyrosine residues were randomly
selected from the total 301 091 tyrosine residues from the
human proteome, and the overlap was determined with
3-nitrotyrosine residues. This bootstrapping process was
repeated 500 times and resulted in an average overlap of
1280+32 tyrosine residues between phosphorylated and
predicted nitrated tyrosine, which is significantly less than
the true overlap ( p , 0.0001, one-sample t-test). The
bootstrapped overlap between phosphorylated and exper-
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Figure 3. Two Sample Logos for 10 residues immediate adjacent to (a) predicted nitrated versus non-nitrated tyrosine residues and (b) experimentally validated
nitrated tyrosine versus non-nitrated tyrosine residues. Amino acids with high propensity for occurrence in a-helices are coloured in red. (c) Two Sample Logos
comparing predicted nitrated tyrosine and non-nitrated tyrosine residues that are located within helices. Positively charged residues are coloured blue while


















Figure 4. Venn diagram showing the overlap between (a) predicted nitrated
tyrosine residues and phosphorylated tyrosine residues, and (b) experimen-
tally validated nitrated tyrosine residues and phosphorylated tyrosine
residues. The number of residues and proteins (in brackets) are shown. Boot-
strapping of expected number of overlap between the phosphotryosine and
nitrotyrosine show that the overlap is significantly higher than by chance





residues, which is also significantly less than the observed
overlap ( p , 0.0001, one-sample t-test).4.7. Predicted nitrated tyrosines are less conserved
than non-nitrated tyrosines while experimentally
validated nitrated tyrosine residues are
more conserved
Examining amino acid conservation across mammals enables
the conservation of tyrosine to be analysed over a reasonably
large set of orthologous proteins. In total, the conser-
vation of 91 342 tyrosine residues was examined. The
tyrosine residues were annotated as nitrated, experimentally
validated nitrated or non-nitrated. A summary of the conser-
vation status of each type of tyrosine is shown in table 2. The
level of conservation between predicted 3-nitrotyrosine
and non-nitrated tyrosine residues was found to be signi-
ficantly lower ( p , 0.0001, x2-test), while the conservation
of experimentally validated 3-nitrotyrosine compared with
non-nitrated tyrosine was significantly higher ( p ¼ 0.0028,
x2-test). To examine this trend further, the absolute entropy,
C, across all sites was compared across the three tyrosine
types (figure 5). Based on the cumulative frequency distribu-
tion, it is evident that predicted 3-nitrotyrosine residues
show significantly higher sequence entropy compared with
non-nitrated tyrosine residues ( p , 0.0001, Mann–Whitney
U-test), whereas experimentally validated 3-nitrotyrosine
residues show significantly lower sequence entropy com-

























Figure 5. Cumulative frequency distribution of normalized Shannon’s entropy
of predicted nitrated tyrosine (dashed line), experimentally validated nitrated
tyrosine (dotted line) and non-nitrated residues (solid line). Predicted nitrated
tyrosine residues have significantly higher sequence entropy compared with
non-nitrated tyrosine residues ( p , 0.0001, Mann – Whitney U-test), as indi-
cated by reaching higher entropy at lower cumulative frequency.
Experimentally validated nitrated tyrosines have significantly lower entropy
compared with non-nitrated tyrosine residues ( p ¼ 0.0026, Mann – Whitney
U-test), as indicated by requiring the highest cumulative frequency to reach
high entropy.
Table 2. Number and percentage of the nitrated and non-nitrated tyrosine
residues that are conserved across orthologous proteins of 10 mammalian
species. The conservation of predicted 3-nitrotyrosine (nitro) is significantly
lower than non-nitrated tyrosine residues (non-nitrated) ( p , 0.0001, x2-test)
while experimentally validated 3-nitrotyrosine (expt. valid. nitro) is significantly
more conserved than non-nitrated residues ( p ¼ 0.0028, x2-test).
conserved total
nitro 5586 (64.1%) 8718
expt. valid. nitro 141 (78.8%) 179






While there are numerous studies that have demonstrated a role
of the nitration of tyrosine in altering the function of specific
proteins, whether this PTM plays a major role in normal phys-
iological processes at a systems level has not been clear. The low
abundance of 3-nitrotyrosine in the proteome has made the pro-
teome-wide detection of the modification difficult, especially in
in vivo systems. The lack of experimental data to date has made
it unfeasible to perform a proteome-wide characterization of the
biophysical and evolutionary properties of this PTM. Using
GPS-YNO2, a recently developed algorithm that had been
shown to be able to predict nitratable tyrosine with good accu-
racy, a set of putative nitratable tyrosine residues across the
human proteome was generated. To further validate that the
accuracy of GPS-YNO2 can be extrapolated to in vivo nitrated
tyrosine sites, experimentally validated in vivo 3-nitrotyrosine
residues were manually curated, and it was found that 85.7
per cent of all sites were also predicted by the algorithm.
While it is difficult to determine the number of true negatives,it has been established by Liu et al. [40] that GPS-YNO2 has a
specificity of 80.18 per cent. This suggested that predictions
by GPS-YNO2 would generalize well for a proteome-wide
analysis of biophysical and evolutionary trends of 3-nitrotyro-
sine residues.
By performing a comprehensive set of bioinformatics
analyses on the set of nitratable tyrosine, the results show
that there are some biophysical constraints on the prevalence
of 3-nitrotyrosine residues. Specifically, nitrated tyrosine resi-
dues are generally more solvent-accessible than non-nitrated
tyrosine and are more likely to be found in a-helices. Resi-
dues in b-strands are generally less solvent-accessible
compared with a-helices [51] and thus the generally higher
solvent accessibility in 3-nitrotyrosine compared with
non-nitrated tyrosine is consistent with the enrichment of
3-nitrotyrosine found in helices. Since the nitration prediction
algorithm used by GPS-YNO2 is dependent on biochemical/
biophysical features of amino acids adjacent to tyrosine to
predict nitration, the amino acid frequencies surrounding
3-nitrotyrosine were analysed, and it was found that amino
acids that have the highest propensity to form a-helices,
such as methionine, alanine, leucine, glutamate and lysine
[44], are indeed generally enriched (figure 3a,b). Interestingly,
when the sequence adjacent to nitrated and non-nitrated tyro-
sine residues that are found to be in helices are compared,
further enrichment of charged amino acids, lysine and gluta-
mic acid was found. While lysine and glutamic acid are
already considered to be favourable for helix formation,
their further enrichment around nitratable residues suggests
that they may be important in promoting tyrosine nitration.
Indeed, it has been suggested previously that negatively
charged residues may play a role in determining the
selectively of tyrosine nitration [37]. However, the role of
positively charged lysine in tyrosine nitration is unclear.
Coiled coil is a tertiary structural motif in which a number of
helices are coiled together in the form of typically a dimer or a
trimer. Interestingly, performing biological feature enrichment
analysis showed that coiled coils were enriched in nitrated pro-
teins, a finding consistent with the enrichment of a-helices.
Proteins with coiled coil motifs are important in gene regulation
and are found in a number of oncogenic transcription factors,
such as c-jun. The introduction of a bulky chemical group on
tyrosine residues through nitration may affect DNA binding
by affecting the affinity of the coiled coil on the negatively
charged DNA, thereby altering transcriptional regulation.
Phosphotyrosine is a major functional PTM that has the
potential to be significantly impaired by tyrosine nitration.
Previous studies have shown that nitration of a tyrosine
completely abolishes its ability to be phosphorylated [52].
This analysis shows that nitration is statistically more likely
to affect phosphorylatable tyrosine residues than by chance
alone. The increase in overlap between nitrated and phos-
phorlylated tyrosine is likely to be due to an enrichment of
glutamic acid and leucine adjacent to many phosphotyrosine
motifs [53], as these amino acids are also among the most fre-
quently occurring adjacent 3-nitrotyrosine residues (figure 3).
While there are few examples of direct interference of tyrosine
phosphorylation by nitration in vivo, the results presented
here suggest that 3-nitrotyrosine has an elevated potential
to affect phosphotyrosine-mediated signalling pathways. It
should be noted that many phosphotyrosine sites from Phos-
phoSitePlus [45] used in the current analysis are curated from




8all phosphotyrosines have been thoroughly validated. There-
fore, the number of true sites overlapping with nitrotyrosine
sites is likely to be lower than those observed in this study.
Nevertheless, the overall trend of significantly increased
overlap between phosphorylatable and nitratable tyrosine
compared with chance alone, as observed in this study, is
unlikely to change.
The results presented here demonstrate that there are bio-
physical characteristics that make 3-nitrotyrosine more likely
to occur at specific locations within the proteome. On the
other hand, the results also indicate that these biophysical
characteristics are relatively mild. The number of nitratable
tyrosine residues is correlated with the total tyrosine in
proteins, suggesting that the biophysical constraints for tyro-
sine nitration are limited, and consequently it is unlikely that
there are any specific processes that regulate tyrosine
nitration at a proteome level. This is consistent with current
research which has not yet identified specific enzymes
involved in the nitration or the denitration of 3-nitrotyrosine.
Furthermore, by analysing the conservation of tyrosine resi-
dues from human proteins with mammalian orthologues, it
is evident that at the proteome level, predicted 3-nitrotyrosines
are less conserved and have higher sequence entropy com-
pared with non-nitrated tyrosine (table 2 and figure 5). This
suggests that there is negative evolutionary selective pressure
for nitratable tyrosine residues, and also suggests that, in the
majority of cases, nitrotyrosine is probably not involved in
normal cellular processes. This is consistent with the numerous
studies that have implicated 3-nitrotyrosine in disease [9–14]
and is further evidence that formation of 3-nitrotyrosine has
a deleterious effect on cellular function. However, surprisingly,
the subset of experimentally validated nitrated tyrosine shows
a significantly higher level of conservation and has lower
sequence entropy compared with non-nitrated tyrosine (table
2 and figure 5). One possible explanation for this observation
is that mass spectrometry, the method used to experimen-
tally identify nitrated tyrosine sites, preferentially detects
highly expressed proteins [54], and it is known that highly
expressed proteins generally have high sequence conservation
[55]. Furthermore, the number of experimentally validated
3-nitrotyrosine sites with conservation data is low (total of179 sites). This result nevertheless highlights that even small
numbers of 3-nitrotyrosine have the potential to target the
large number of highly conserved tyrosine residues. These con-
served tyrosine residues are possibly functionally important
and their nitration may underlie human diseases.6. Conclusions
This study has demonstrated that there are biophysical con-
straints that influence the ability of a tyrosine to be nitrated,
while, from an evolutionary perspective, this PTM probably
has a deleterious effect on protein function. The biophysical
constraints observed may arise due to specific chemistries
that are favourable for the nitration of tyrosine, or perhaps
the constraints dictate the physical accessibility of the tyro-
sine for nitration. In either case, the biophysical constraints
appear to make 3-nitrotyrosine more likely to occur at
a-helices and phosphorylatable tyrosine residues, meaning
that spontaneous nitration as a result of oxidative/nitrosative
stress does have an increased likelihood to interfere with gene
regulation and signal transduction functions.
While this analysis has been performed using a set of pre-
dicted 3-nitrotyrosine sites in the human proteome, the fact
that the prediction algorithm GPS-YNO2 achieved over 85.7
per cent accuracy in predicting endogenously nitrated tyro-
sine residues and overall 73.1 per cent of all experimentally
determined nitrated tyrosine residues would suggest that
the majority of the sites used in this proteome-wide analysis
are likely to be reliable. Therefore, the findings described
should reflect the actual occurrence of 3-nitrotyrosine in the
human proteome.7. Acknowledgements
This work is financially supported by an Australian Post-
graduate Award (J.Y.N.), a Medical Advances Without
Animals scholarship (J.Y.N.), a UNSW Vice-Chancellor’s
post-doctoral fellowship (J.W.H.W.) and a Cancer Institute
NSW Early Career Fellowship (J.W.H.W.).References1. Sokolovsky M, Riordan JF, Vallee BL. 1966
Tetranitromethane: a reagent for the
nitration of tyrosyl residues in proteins.
Biochemistry 5, 3582 – 3589. (doi:10.1021/
bi00875a029)
2. Gaut JP, Byun J, Tran HD, Heinecke JW.
2002 Artifact-free quantification of free 3-
chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine
in human plasma by electron capture-negative
chemical ionization gas chromatography mass
spectrometry and liquid chromatography-
electrospray ionization tandem mass spectrometry.
Anal. Biochem. 300, 252 – 259. (doi:10.1006/abio.
2001.5469)
3. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E,
Isobe C. 1999 Alterations of 3-nitrotyrosine
concentration in the cerebrospinal fluid duringaging and in patients with Alzheimer’s disease.
Neurosci. Lett. 269, 52 – 54. (doi:10.1016/S0304-
3940(99)00406-1)
4. Palazzolo-Ballance AM, Suquet C, Hurst JK. 2007
Pathways for intracellular generation of oxidants
and tyrosine nitration by a macrophage cell line.
Biochemistry 46, 7536 – 7548. (doi:10.1021/
bi700123s)
5. Ischiropoulos H, Zhu L, Beckman JS. 1992
Peroxynitrite formation from macrophage-derived
nitric oxide. Arch. Biochem. Biophys. 298, 446 – 451.
(doi:10.1016/0003-9861(92)90433-W)
6. Huie RE, Padmaja S. 1993 The reaction of NO with
superoxide. Free Radic. Res. Commun. 18, 195 – 199.
(doi:10.3109/10715769309145868)
7. Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q,
Chen C. 2006 Nitrotyrosine and chlorotyrosine:clinical significance and biological functions in the
vascular system. J. Surg. Res. 133, 143 – 149.
(doi:10.1016/j.jss.2005.10.008)
8. Oury TD, Tatro L, Ghio AJ, Piantadosi CA. 1995
Nitration of tyrosine by hydrogen peroxide and
nitrite. Free Radic. Res. 23, 537 – 547. (doi:10.3109/
10715769509065275)
9. Maciag AE, Chakrapani H, Saavedra JE,
Morris NL, Holland RJ, Kosak KM, Shami PJ,
Anderson LM, Keefer LK. 2011 The nitric
oxide prodrug JS-K is effective against non-
small-cell lung cancer cells in vitro and in vivo:
involvement of reactive oxygen species.
J. Pharmacol. Exp. Ther. 336, 313 – 320.
(doi:10.1124/jpet.110.174904)
10. Aslan M, Dogan S. 2011 Proteomic detection




9cardiovascular disease. J. Proteomics 74,
2274 – 2288. (doi:10.1016/j.jprot.2011.05.029)
11. Lawless MW, O’Byrne KJ, Gray SG. 2009 Oxidative stress
induced lung cancer and COPD: opportunities for
epigenetic therapy. J. Cell Mol. Med. 13, 2800 – 2821.
(doi:10.1111/j.1582-4934.2009.00845.x)
12. Amann A, Corradi M, Mazzone P, Mutti A. 2011
Lung cancer biomarkers in exhaled breath. Expert
Rev. Mol. Diagn. 11, 207 – 217. (doi:10.1586/
erm.10.112)
13. Sugiura H, Komaki Y, Koarai A, Ichinose M. 2008
Nitrative stress in refractory asthma. J. Allergy
Clin. Immunol. 121, 355 – 360. (doi:10.1016/j.jaci.
2007.11.009)
14. Butterfield DA, Reed T, Sultana R. 2011 Roles of
3-nitrotyrosine- and 4-hydroxynonenal-modified
brain proteins in the progression and pathogenesis
of Alzheimer’s disease. Free Radic. Res. 45, 59 – 72.
(doi:10.3109/10715762.2010.520014)
15. Yamakura F, Taka H, Fujimura T, Murayama K. 1998
Inactivation of human manganese-superoxide
dismutase by peroxynitrite is caused by exclusive
nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol.
Chem. 273, 14 085 – 14 089. (doi:10.1074/jbc.273.
23.14085)
16. Moreno DM, Marti MA, De Biase PM, Estrin DA,
Demicheli V, Radi R, Boechi L. 2011 Exploring the
molecular basis of human manganese superoxide
dismutase inactivation mediated by tyrosine 34
nitration. Arch. Biochem. Biophys. 507, 304 – 309.
(doi:10.1016/j.abb.2010.12.011)
17. Vadseth C et al. 2004 Pro-thrombotic state induced
by post-translational modification of fibrinogen by
reactive nitrogen species. J. Biol. Chem. 279, 8820 –
8826. (doi:10.1074/jbc.M306101200)
18. Quint P, Reutzel R, Mikulski R, McKenna R,
Silverman DN. 2006 Crystal structure of nitrated
human manganese superoxide dismutase:
mechanism of inactivation. Free Radic. Biol.
Med. 40, 453 – 458. (doi:10.1016/j.freeradbiomed.
2005.08.045)
19. Tao L et al. 2006 Nitrative inactivation of
thioredoxin-1 and its role in postischemic
myocardial apoptosis. Circulation 114, 1395 – 1402.
(doi:10.1161/CIRCULATIONAHA.106.625061)
20. Yin T, Hou R, Liu S, Lau WB, Wang H, Tao L. 2010
Nitrative inactivation of thioredoxin-1 increases
vulnerability of diabetic hearts to ischemia/
reperfusion injury. J. Mol. Cell Cardiol. 49,
354 – 361. (doi:10.1016/j.yjmcc.2010.05.002)
21. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. 1996
Effects of peroxynitrite-induced protein
modifications on tyrosine phosphorylation and
degradation. FEBS Lett. 385, 63 – 66. (doi:10.1016/
0014-5793(96)00347-X)
22. Kong SK, Yim MB, Stadtman ER, Chock PB. 1996
Peroxynitrite disables the tyrosine phosphorylation
regulatory mechanism: lymphocyte-specific tyrosine
kinase fails to phosphorylate nitrated cdc2(6 –
20)NH2 peptide. Proc. Natl Acad. Sci. USA 93,
3377 – 3382. (doi:10.1073/pnas.93.8.3377)
23. Monteiro HP, Arai RJ, Travassos LR. 2008 Protein
tyrosine phosphorylation and protein tyrosinenitration in redox signaling. Antioxid. Redox Signal
10, 843 – 889. (doi:10.1089/ars.2007.1853)
24. Mallozzi C, Ceccarini M, Camerini S, Macchia G,
Crescenzi M, Petrucci TC, Di Stasi AM. 2009
Peroxynitrite induces tyrosine residue modifications
in synaptophysin C-terminal domain, affecting its
interaction with src. J. Neurochem. 111, 859 – 869.
(doi:10.1111/j.1471-4159.2009.06378.x)
25. Brito C, Naviliat M, Tiscornia AC, Vuillier F, Gualco G,
Dighiero G, Radi R, Cayota AM. 1999 Peroxynitrite
inhibits T lymphocyte activation and proliferation by
promoting impairment of tyrosine phosphorylation
and peroxynitrite-driven apoptotic death.
J. Immunol. 162, 3356 – 3366.
26. MacMillan-Crow LA, Greendorfer JS, Vickers SM,
Thompson JA. 2000 Tyrosine nitration of c-SRC
tyrosine kinase in human pancreatic ductal
adenocarcinoma. Arch. Biochem. Biophys. 377,
350 – 356. (doi:10.1006/abbi.2000.1799)
27. Aburima A, Riba R, Naseem KM. 2010 Peroxynitrite
causes phosphorylation of vasodilator-stimulated
phosphoprotein through a PKC dependent
mechanism. Platelets 21, 421 – 428. (doi:10.3109/
09537104.2010.483296)
28. Mondoro TH, Shafer BC, Vostal JG. 1997
Peroxynitrite-induced tyrosine nitration and
phosphorylation in human platelets. Free Radic.
Biol. Med. 22, 1055 – 1063. (doi:10.1016/S0891-
5849(96)00510-2)
29. Dekker F, Abello N, Wisastra R, Bischoff R. 2012
Enrichment and detection of tyrosine-nitrated
proteins. Curr. Protoc. Protein Sci. 69, 14.13.1 –
14.13.19. (doi:10.1002/0471140864.ps1413s69)
30. MacMillan-Crow LA, Thompson JA. 1999
Immunoprecipitation of nitrotyrosine-containing
proteins. Methods Enzymol. 301, 135 – 145. (doi:10.
1016/S0076-6879(99)01076-9)
31. Zhan X, Desiderio DM. 2009 Mass spectrometric
identification of in vivo nitrotyrosine sites in the
human pituitary tumor proteome. Methods Mol.
Biol. 566, 137 – 163. (doi:10.1007/978-1-59745-
562-6_10)
32. Tsikas D, Mitschke A, Gutzki FM. 2012 Measurement
of 3-nitro-tyrosine in human plasma and urine by
gas chromatography-tandem mass spectrometry.
Methods Mol. Biol. 828, 255 – 270. (doi:10.1007/
978-1-61779-445-2_20)
33. Tsikas D. 2012 Analytical methods for 3-
nitrotyrosine quantification in biological samples:
the unique role of tandem mass spectrometry.
Amino Acids 42, 45 – 63. (doi:10.1007/s00726-010-
0604-5)
34. Dremina ES, Li X, Galeva NA, Sharov VS, Stobaugh
JF, Schoneich C. 2011 A methodology for
simultaneous fluorogenic derivatization and
boronate affinity enrichment of 3-nitrotyrosine-
containing peptides. Anal. Biochem. 418, 184 – 196.
(doi:10.1016/j.ab.2011.07.024)
35. Zhang Q et al. 2007 A method for selective
enrichment and analysis of nitrotyrosine-
containing peptides in complex proteome
samples. J. Proteome Res. 6, 2257 – 2268.
(doi:10.1021/pr0606934)36. Ghesquiere B et al. 2009 In vitro and
in vivo protein-bound tyrosine nitration
characterized by diagonal chromatography. Mol.
Cell Proteomics 8, 2642 – 2652. (doi:10.1074/mcp.
M900259-MCP200)
37. Souza JM, Daikhin E, Yudkoff M, Raman CS,
Ischiropoulos H. 1999 Factors determining the
selectivity of protein tyrosine nitration. Arch.
Biochem. Biophys. 371, 169 – 178. (doi:10.1006/
abbi.1999.1480)
38. Abello N, Kerstjens HA, Postma DS, Bischoff R. 2009
Protein tyrosine nitration: selectivity,
physicochemical and biological consequences,
denitration, and proteomics methods for the
identification of tyrosine-nitrated proteins.
J. Proteome Res. 8, 3222 – 3238. (doi:10.1021/
pr900039c)
39. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C.
2004 Aspects, mechanism, and biological relevance
of mitochondrial protein nitration sustained by
mitochondrial nitric oxide synthase. Am. J. Physiol.
Heart Circ. Physiol. 286, H22 – H29. (doi:10.1152/
ajpheart.00766.2003)
40. Liu Z, Cao J, Ma Q, Gao X, Ren J, Xue Y. 2011 GPS-
YNO2: computational prediction of tyrosine nitration
sites in proteins. Mol. Biosyst. 7, 1197 – 1204.
(doi:10.1039/c0mb00279h)
41. Huang DW, Sherman BT, Lempicki RA. 2009
Systematic and integrative analysis of large gene
lists using DAVID bioinformatics resources. Nat.
Protoc. 4, 44 – 57. (doi:10.1038/nprot.2008.211)
42. Kabsch W, Sander C. 1983 Dictionary of protein
secondary structure: pattern recognition of
hydrogen-bonded and geometrical features.
Biopolymers 22, 2577 – 2637. (doi:10.1002/bip.
360221211)
43. Vacic V, Iakoucheva LM, Radivojac P. 2006 Two
Sample Logo: a graphical representation of the
differences between two sets of sequence
alignments. Bioinformatics 22, 1536 – 1537. (doi:10.
1093/bioinformatics/btl151)
44. Pace CN, Scholtz JM. 1998 A helix propensity scale
based on experimental studies of peptides and
proteins. Biophys. J. 75, 422 – 427. (doi:10.1016/
S0006-3495(98)77529-0)
45. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E,
Zhang B. 2004 PhosphoSite: a bioinformatics
resource dedicated to physiological protein
phosphorylation. Proteomics 4, 1551 – 1561. (doi:10.
1002/pmic.200300772)
46. Waterhouse RM, Zdobnov EM, Tegenfeldt F, Li J,
Kriventseva EV. 2011 OrthoDB: the hierarchical
catalog of eukaryotic orthologs in 2011. Nucleic
Acids Res. 39, D283 – D288. (doi:10.1093/nar/
gkq930)
47. Thompson JD, Higgins DG, Gibson TJ. 1994 CLUSTAL
W: improving the sensitivity of progressive multiple
sequence alignment through sequence weighting,
position-specific gap penalties and weight matrix
choice. Nucleic Acids Res. 22, 4673 – 4680. (doi:10.
1093/nar/22.22.4673)
48. Johansson F, Toh H. 2010 A comparative
study of conservation and variation scores.
rsob.royalsocietypublishing.org
10BMC Bioinform. 11, 388. (doi:10.1186/1471-2105-
11-388)
49. Sun T et al. 2011 Activation of multiple proto-
oncogenic tyrosine kinases in breast cancer via loss
of the PTPN12 phosphatase. Cell 144, 703 – 718.
(doi:10.1016/j.cell.2011.02.003)
50. Linger RM, Keating AK, Earp HS, Graham DK. 2008
TAM receptor tyrosine kinases: biologic functions,
signaling, and potential therapeutic targeting in
human cancer. Adv. Cancer Res. 100, 35 – 83.
(doi:10.1016/S0065-230X(08)00002-X)51. Lins L, Thomas A, Brasseur R. 2003 Analysis of
accessible surface of residues in proteins. Protein Sci.
12, 1406 – 1417. (doi:10.1110/ps.0304803)
52. Takakusa H, Mohar I, Kavanagh TJ, Kelly EJ, Kaspera
R, Nelson SD. 2012 Protein tyrosine nitration of
mitochondrial carbamoyl phosphate synthetase 1
and its functional consequences. Biochem. Biophys.
Res. Commun. 420, 54 – 60. (doi:10.1016/j.bbrc.
2012.02.114)
53. Amanchy R, Periaswamy B, Mathivanan S, Reddy R,
Tattikota SG, Pandey A. 2007 A curatedcompendium of phosphorylation motifs.
Nat. Biotechnol. 25, 285 – 286. (doi:10.1038/
nbt0307-285)
54. Wu L, Han DK. 2006 Overcoming the dynamic range
problem in mass spectrometry-based shotgun
proteomics. Expert Rev. Proteomics 3, 611 – 619.
(doi:10.1586/14789450.3.6.611)
55. Drummond DA, Bloom JD, Adami C, Wilke CO,
Arnold FH. 2005 Why highly expressed proteins
evolve slowly. Proc. Natl Acad. Sci. USA 102,
14 338 – 14 343. (doi:10.1073/pnas.0504070102)Open
Biol3:120148
